References
- Antinori A, Ammassari A, Cinque P, Toma L, Govoni A, Soldani F, Giancola ML, Grisetti S, Pierotti C, Fausti C, Finazzi MG, Bini T, Del Grosso B, Cristiano L, Corsi P, Fasulo G, Mena M, Guaraldi G, Arcidiacono MI, Monno L, Gigli B, Fibbia GC, Gentile M, Mastroianni A, Speranza F, d'Arminio Monforte A, Rezza G, Ippolito G (2001). Shift of prevalence and selected characteris-tics in HIV-1-related neurologic disorders in HAART era: data from Italian Register Investigative Neuro AIDS (IRINA). The eighth conference on retroviruses and op-portunistic infections, p 45.
- Berenguer J, Miralles P, Arrizabalaga J, Ribera E, Dronda F, Baraia J, Domingo P, Marquez M, Rodriguez -Arrondo FJ, Laguna F, Rubio R, Lopez-Aldeguer J, De Meguel V, Gesida 11/99 Study Group (2001). Clinical course and prognostic factors of AIDS-associated progressive mul-tifocal leukoencephalopathy (PML) in patients treated with HAART. The eighth conference on retroviruses and opportunistic infections, p 45.
- Berger JR, Pall L, Lanska D, Whiteman M (1998). Progres-sive multifocal leukoencephalopathy in patients with HIV infection. J NeuroVirol 4: 59–68.
- Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999). HAART im-proves prognosis in HIV-associated progressive multifo-cal leukoencephalopathy. Neurology 52: 623–625.
- De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Paglia MG, Govoni A, Murri R, Testa L,
- d'Arminio Monforte A, Antinori A (2000). Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifoc al leukoen-cephalopathy. AIDS 14: 1–5.
- Dupont B, Fish D, McGuire D, Royal W, Singer E, Goodkin K, Garden D, Martino H, Hearn S, Ross G, Beckman R (2001). 21-Day continuous infusion of Topotecan in AIDS-associated progressive multifoc al leukoen-cephalopathy (PML). The eighth conference on retro-viruses and opportunistic infections, p 223.
- Hall CD, Dafni U, Simpson D, Clifford DB, Wetherill PE, Cohen B, McArthur JC, Hollander H, Yiannoutsos C, Major E, Millar L, Timpone J, AIDS Clinical Trials Group 243 Team (1998). Failure of cytarabine in progressive multifoc al leukoencephalopathy as s ociate d with human immunodeficiency virus infection. N Engl I Med 338: 1345–1351.
- Marra CM, Rajicic N, Barker DE, Cohen B, Clifford D, ACTG 363 Team (2001). Prospective pilot study of cido-fovir for HIV-associated progressive multifoc al leukoen-cephalopathy (PML). The eighth conference on retro-viruses and opportunistic infections, p 223.
- Yiannoutsos CT, Major EO, Curfman B, Jensen PN, Gravell M, Hou J, Clifford DB, Hall, CD (1999). Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syn-drome patients with biopsy-proven progressive mul-tifocal leukoencephalopathy. Ann Neurol 45: 816–820.